Background/Aims: Colonoscopy can detect precancerous lesions, which can subsequently be removed and reduce incidences of and mortality from colorectal cancer (CRC). However, recently published data have highlighted a significant rate of CRC in patients who previously underwent colonoscopy. Among many reasons, incomplete resection has been considered as a significant contributor. However, to date, there have only been a few studies regarding incompletely resected polyps, especially advanced colorectal adenoma (ACA). Hence, we aimed to evaluate the prognosis of incompletely resected ACA. Methods: We retrospectively reviewed the medical records of patients with ACA who had underwent endoscopic treatment with incomplete resection. The primary outcomes were (1) the incomplete resection rate of ACA, as determined by a histopathologic examination and (2) the recurrence rate of incompletely resected ACA. We also investigated the probable contributing factors that may have led to a relapse of incompletely resected ACA. Results: A total of 7,105 patients had their colorectal polyps resected by endoscopic treatment, and 2,233 of these were considered as ACA. Of these, 354 polyps (15.8%) were resected incompletely, and only 163 patients were followed-up. Of those followed-up, 31 patients (19.0%) experienced local recurrence. The risk factors for recurrence after incomplete resection were evaluated; age, morphology of adenoma, and use of rescue therapy, such as argon plasma coagulation, were found to be associated with adenoma recurrence. Conclusions: Incompletely resected ACA in older patients or in patients with sessile-type adenomas should be monitored strictly, and if incomplete resection is suspected, rescue therapy must be considered. (Korean J Gastroenterol 2017;70:33-38) 
INTRODUCTION
Colorectal cancer (CRC) is an important health issue worldwide, due to its high incidence and mortality rate. 1, 2 Adenomatous polyps are generally accepted to be the precursors of most CRC cases. Progression from adenoma to CRC is a multistep process, accompanied by alterations in the expression of several suppressor genes that result in abnormalities in cell
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The Korean Journal of Gastroenterology regulation. Progression takes place over a period of 10 to 15 years. 3 Colonoscopy is a useful tool for the detection and removal of precancerous lesions (adenomatous polyps), and its use can reduce CRC incidence and mortality. However, recent data have highlighted a significant rate of CRC despite previous colonoscopy. The so-called interval cancer, defined as a cancer diagnosed between screening examination and post-screening surveillance, 4, 5 has raised concerns regarding the effectiveness of colonoscopy and colonoscopic polypectomy.
There are three plausible reasons for interval CRCs. First, interval cancers may arise from lesions that went unnoticed during a colonoscopy. About 70-80% of interval cancers likely result from lesions that went unnoticed. 6 Second, interval cancers can result from rapidly progressing polyps that were not present at the time of colonoscopy. This is based on the observation that some cancers have genetic features associated with extremely rapid progression. 7 Third, interval cancers can result from incompletely resected lesions. Incomplete resection of lesions may account for 10-27% of interval cancers. 4, 8, 9 Although incomplete resection has been known as a significant contributor to interval cancer, there has only been a few studies evaluating incomplete resection of polyps, especially regarding advanced colorectal adenoma (e.g. >1 cm in size or containing high-grade dysplasia or a villous component). Hence, we retrospectively studied the recurrence rate of advanced colorectal adenoma that was incompletely resected and investigated the possible contributing factors that may lead to relapse.
SUBJECTS AND METHODS

Patients
We retrospectively surveyed patients who had advanced colorectal adenoma and resulted in incomplete resection by either endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD), between August 2003 and March 2015. Patients who were not followed-up after endoscopic treatment for advanced colorectal adenoma were excluded.
Methods
We reviewed patient records by using EMR and a digitalized picture archiving communication system. The institutional review board at our institution approved this study, complying with the Helsinki declaration.
The primary outcomes were (1) 
Statistical analysis
Data are expressed as the mean±standard deviation.
Variables were analyzed using the independent t-test or chi-square test. Analyses were performed using SPSS version 15.0 (SPSS Inc., Chicago, IL, USA). p-values of ≤0.05
were considered statistically significant. were resected incompletely, and only 163 patients were followed-up (Fig. 1) .
We finally analyzed these 163 patients (mean age, 66.5±10 years; 65.0% male), who with incompletely resected advanced colorectal adenoma and received at least one colonoscopy after endoscopic treatment. Most colonoscopies were performed for screening purposes (63.1%). Table 1 shows the baseline characteristics of patients with incompletely resected advanced colorectal adenoma.
Characteristics of incompletely resected advanced colorectal adenoma
A total of 163 cases of incompletely resected advanced colorectal adenoma were followed-up. The time between endoscopic resection and first colonoscopic follow-up in this study was ranged from 3 to 72 months, which was highly variable. The mean polyp size was 12.3 mm (±6.7 mm standard deviation); in 12 cases (7.3%), the polyp was more than 20 mm in size. Most polyps (112, 68.7%) were between 10 mm and 20 mm in size. Ninety polyps (55.2%) were located in the right colon, and 114 cases (69.9%) were morphologically considered the sessile type.
Of the total number of advanced colorectal adenomas, 90 cases (55.2%) were classified as tubulovillous or villous adenomas. High-grade dysplasia was found in 13 cases (7.9%). Thirty-one patients (19.0%), experienced recurrence after incomplete resection of advanced colorectal adenoma.
The period from endoscopic treatment of advanced colorectal adenoma to recurrence was 3-36 months. Table 2 shows the characteristics of incompletely resected advanced colorectal adenomas. 
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The sex of patients, type of advanced colorectal adenoma (pathology or size criteria), location, size of polyp, en bloc vs.
piecemeal resection, resection method (EMR or ESD), and quality of bowel preparation were not significantly associated with recurrence (Table 3) . Moreover, logistic multivariate regression analysis showed that age, morphology of adenoma, and rescue therapy were significant predictors of recurrence after incomplete resection of advanced colorectal adenoma (Table 4) .
DISCUSSION
Generally, advanced colorectal adenoma is present in 9.6% of all asymptomatic patients. 11 However, in our study, the incidence of advanced colorectal adenoma was 31.4%, which is very high compared with previous reports. This difference may be attributable to the differences in the study population; our population consisted of patients who had undergone EMR or ESD, and some patients were referred from the primary health care system for endoscopic treatment due to unusually large colonic polyps. We evaluated patients treated with EMR or ESD, and, generally, large polyps are treated using these methods; therefore, patients with larger polyps were more likely to be included in our study.
Our study shows that recurrence after endoscopic treatment for advanced colorectal adenoma occurs in approximately 19% of cases. It has previously been reported that that the recurrence rate of ACA after endoscopic resection is estimated to be 17.4-19.8%. [12] [13] [14] However, these studies only included cases of completely resected ACA 12, 13 or ACA regardless of complete resection. 14 Besides, these studies were different from ours in that they included both local recurrence and metachronus recurrence of ACA when evaluating the recurrence of ACA after endoscopic resection. There may be two reasons that we did not include metachronus recurrence in our study.
First, we investigated only the incompletely resected ACA; second, the definition of local recurrence has been broader than that used in other studies. In our study, local recurrence included not only the Higaki criteria, but also adenomatous lesions in the same colonic segment found 5 cm away from the previous endoscopic treatment site, if a previous resection site could not be found at the time of follow-up colonoscopy.
Therefore, our definition may include lesions that had previously gone unnoticed in the same segment as the One report found that cancer occurred in 5% of patients with residual lesions after primary endoscopic treatment of an adenoma. 15 The subjects in our study were patients with advanced colorectal adenomas; hence, the incidence of invasive cancer in this population is expected to be higher than in populations with other types of polyps. [16] [17] [18] Nonetheless, no patient in our study developed invasive cancer following incomplete resection of advanced colorectal adenoma.
Our study showed that adjunctive ablation of resection sites of advanced colorectal adenomas may be useful in reducing local recurrence. In patients of advanced age or with sessile polyps, the local recurrence rate was higher than in other patients. This result suggests that incompletely resected advanced colorectal adenomas in older patients or in patients with sessile-type adenomas have to be strictly monitored. However, it is worth noting that whether strict monitoring for patients over the age of 70 is valuable or impactful, given that their life expectancies are relatively short.
This study has several limitations to consider. First, the number of patients was small, which introduces the possibility of a type II statistical error. Second, the retrospective nature of the study may have caused selection bias. Accordingly, further large-scale prospective studies are required to confirm our findings.
There have been a few previous studies investigating the recurrence and its risk factors after endoscopic resection of ACA. [12] [13] [14] However, our study offers a unique point: We analyzed incompletely resected ACA, unlike the previous studies.
Moreover, in our study, local recurrence included not only the Higaki criteria but also adenomatous lesions in the same colonic segment found within 5 cm away from the previous endoscopic treatment site, if the previous resection site could not be found at the time of follow-up colonoscopy. We suggested this criteria because polyps with a size of less than 10 mm are not easily detected after endoscopic treatment and a loop formed during manipulation of the colonoscopy is considered to cause errors within plus or minus 5 cm. In addition, endoscopists in our hospital described how far the polyps were from the anal verge when defining the location of the polyps. We believe that this criteria can be used as a new index in evaluating the recurrence of polyps.
In our study, we found that age of patients was a statistically significant cause of recurrence. The mechanism for this has not been fully elucidated. However, as there have been
reports showing that age is a risk factor for the prevalence of colorectal adenoma 19, 20 and that the recurrence increased among older patients on the follow-up colonoscopy after endoscopic removal of adenoma, 21, 22 we can presume a similar mechanism for a possible increase in local recurrence.
For this, we think that the prospective study using big data should be supplemented in the near future.
In conclusion, this study shows that age of more than 70 years and sessile polyps are significant predictors for recurrence of incompletely resected advanced colorectal adenoma. Moreover, we showed that rescue therapy, such as APC, can reduce the recurrence rate. We recommend that in patients of older age with incompletely resected advanced colorectal adenomas or in patients with sessile-type adenomas, strict monitoring is necessary, and if incomplete resection of adenoma is suspected in these patients, rescue therapy should be considered. However, for elderly patients over the age of 70, life expectancy should be considered when planning for follow-up colonoscopy.
